Variables

N = 69

%

Surgical approach

Laparoscopy

4

5.80%

Open

65

94.20%

Staging status

Complete

8

11.60%

Incomplete

22

31.90%

Unstaged

39

56.50%

Surgical procedure

Bilateral cystectomy

5

7.20%

TAH-BSO

34

49.30%

Unilateral cystectomy

11

15.90%

USO

17

24.60%

USO + hysterectomy

1

1.40%

USO + unilateral cystectomy

1

1.40%

Complications

No

60

87.00%

Yes

9

13.00%

Type of surgical complication (n = 9)

Bladder injury

1

11.10%

Burst Abdomen

1

11.10%

Ureteric injury

3

33.40%

Port site nodules

1

11.10%

Iliac vessel injury and repair

1

11.10%

Tubo-ovarian abscess & drainage

1

11.10%

Severe hemorrhage - vitally unstable (ICU)

1

11.10%

Laterality

Bilateral

19

27.50%

Unilateral

50

72.50%

Peritoneal implants

No

63

91.30%

Yes

6

8.70%

Frozen section

No

66

95.70%

Yes

3

4.30%

Omentectomy

No

42

60.90%

Yes

27

39.10%

Omentum involvement

No

24

88.90%

Yes

3

11.10%

Appendectomy

No

63

91.30%

Yes

6

8.70%

Appendix involvement

No

6

100.00%

Variables

N = 69

%

Pelvic lymphadenectomy

No

61

88.40%

Yes

8

11.60%

Number of removed LNs Median (Range)

3.0 (2.0-18.0)

Histological type

Brenner's

1

1.40%

Cellular fibroma

1

1.40%

Endometroid

3

4.30%

Mucinous

22

31.90%

Sero-mucinous

3

4.30%

Serous

39

56.50%

Maximum tumor diameter (Mean ± Sd)

16.6 ± 8.2

Micro invasion

No

61

88.40%

Yes

8

11.60%

Papillary projections

No

26

37.70%

Yes

43

62.30%